Some outcomes they considered included cognitive deficit, dementia, migraine, insomnia, nicotine misuse, depression, and anxiety
Its also important to note that for patients using Wegovy to reduce heart attack and stroke risk which Australias Therapeutic Goods Administration recently approved it for theres no evidence that cardiovascular benefits will be achieved at lower-than-recommended doses
More serious side effects are rare , but it is important to recognise warning signs and seek medical advice when needed
"FDA reports no link between weight-loss drugs and suicidal thoughts"
Wegovy significantly reduced the risk of major adverse cardiovascular events (cardiovascular death, heart attack and stroke), which occurred in 6.5% of participants who received Wegovy compared to 8% of participants who received placebo